183 related articles for article (PubMed ID: 19635826)
1. Antigen display, T-cell activation, and immune evasion during acute and chronic ehrlichiosis.
Nandi B; Chatterjee M; Hogle K; McLaughlin M; MacNamara K; Racine R; Winslow GM
Infect Immun; 2009 Oct; 77(10):4643-53. PubMed ID: 19635826
[TBL] [Abstract][Full Text] [Related]
2. CD4 T-cell epitopes associated with protective immunity induced following vaccination of mice with an ehrlichial variable outer membrane protein.
Nandi B; Hogle K; Vitko N; Winslow GM
Infect Immun; 2007 Nov; 75(11):5453-9. PubMed ID: 17698576
[TBL] [Abstract][Full Text] [Related]
3. Persistent infection contributes to heterologous protective immunity against fatal ehrlichiosis.
Thirumalapura NR; Crossley EC; Walker DH; Ismail N
Infect Immun; 2009 Dec; 77(12):5682-9. PubMed ID: 19805532
[TBL] [Abstract][Full Text] [Related]
4. Protective heterologous immunity against fatal ehrlichiosis and lack of protection following homologous challenge.
Thirumalapura NR; Stevenson HL; Walker DH; Ismail N
Infect Immun; 2008 May; 76(5):1920-30. PubMed ID: 18285501
[TBL] [Abstract][Full Text] [Related]
5. Immunization with Ehrlichia P28 outer membrane proteins confers protection in a mouse model of ehrlichiosis.
Crocquet-Valdes PA; Thirumalapura NR; Ismail N; Yu X; Saito TB; Stevenson HL; Pietzsch CA; Thomas S; Walker DH
Clin Vaccine Immunol; 2011 Dec; 18(12):2018-25. PubMed ID: 22030371
[TBL] [Abstract][Full Text] [Related]
6. Overproduction of TNF-alpha by CD8+ type 1 cells and down-regulation of IFN-gamma production by CD4+ Th1 cells contribute to toxic shock-like syndrome in an animal model of fatal monocytotropic ehrlichiosis.
Ismail N; Soong L; McBride JW; Valbuena G; Olano JP; Feng HM; Walker DH
J Immunol; 2004 Feb; 172(3):1786-800. PubMed ID: 14734762
[TBL] [Abstract][Full Text] [Related]
7. Impaired germinal center responses and suppression of local IgG production during intracellular bacterial infection.
Racine R; Jones DD; Chatterjee M; McLaughlin M; Macnamara KC; Winslow GM
J Immunol; 2010 May; 184(9):5085-93. PubMed ID: 20351185
[TBL] [Abstract][Full Text] [Related]
8. NK Cell-Mediated Regulation of Protective Memory Responses against Intracellular Ehrlichial Pathogens.
Habib S; El Andaloussi A; Hisham A; Ismail N
PLoS One; 2016; 11(4):e0153223. PubMed ID: 27092553
[TBL] [Abstract][Full Text] [Related]
9. T-Cell-independent humoral immunity is sufficient for protection against fatal intracellular ehrlichia infection.
Bitsaktsis C; Nandi B; Racine R; MacNamara KC; Winslow G
Infect Immun; 2007 Oct; 75(10):4933-41. PubMed ID: 17664264
[TBL] [Abstract][Full Text] [Related]
10. Early induction of interleukin-10 limits antigen-specific CD4⁺ T cell expansion, function, and secondary recall responses during persistent phagosomal infection.
Singh AK; Thirumalapura NR
Infect Immun; 2014 Oct; 82(10):4092-103. PubMed ID: 25024370
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Ehrlichia P29 protein induces a protective immune response in a mouse model of ehrlichiosis.
Thirumalapura NR; Crocquet-Valdes PA; Saito TB; Thomas S; McBride JW; Walker DH
Vaccine; 2013 Dec; 31(50):5960-7. PubMed ID: 24144475
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of immunity to Ehrlichia muris: a model of monocytotropic ehrlichiosis.
Feng HM; Walker DH
Infect Immun; 2004 Feb; 72(2):966-71. PubMed ID: 14742542
[TBL] [Abstract][Full Text] [Related]
13. CD11c expression identifies a population of extrafollicular antigen-specific splenic plasmablasts responsible for CD4 T-independent antibody responses during intracellular bacterial infection.
Racine R; Chatterjee M; Winslow GM
J Immunol; 2008 Jul; 181(2):1375-85. PubMed ID: 18606692
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-12 as an adjuvant promotes immunoglobulin G and type 1 cytokine recall responses to major surface protein 2 of the ehrlichial pathogen Anaplasma marginale.
Tuo W; Palmer GH; McGuire TC; Zhu D; Brown WC
Infect Immun; 2000 Jan; 68(1):270-80. PubMed ID: 10603398
[TBL] [Abstract][Full Text] [Related]
15. The omentum is a site of protective IgM production during intracellular bacterial infection.
Jones DD; Racine R; Wittmer ST; Harston L; Papillion AM; Dishaw LM; Randall TD; Woodland DL; Winslow GM
Infect Immun; 2015 May; 83(5):2139-47. PubMed ID: 25776744
[TBL] [Abstract][Full Text] [Related]
16. Expressed Salmonella antigens within macrophages enhance the proliferation of CD4+ and CD8+ T lymphocytes by means of bystander dendritic cells.
Eguchi M; Sekiya Y; Kikuchi Y; Takaya A; Yamamoto T; Matsui H
FEMS Immunol Med Microbiol; 2007 Aug; 50(3):411-20. PubMed ID: 17573927
[TBL] [Abstract][Full Text] [Related]
17. Type I interferon contributes to noncanonical inflammasome activation, mediates immunopathology, and impairs protective immunity during fatal infection with lipopolysaccharide-negative ehrlichiae.
Yang Q; Stevenson HL; Scott MJ; Ismail N
Am J Pathol; 2015 Feb; 185(2):446-61. PubMed ID: 25481711
[TBL] [Abstract][Full Text] [Related]
18. Rapid loss of early antigen-presenting activity of lymph node dendritic cells against Ag85A protein following Mycobacterium bovis BCG infection.
Xu Z; Xia A; Li X; Zhu Z; Shen Y; Jin S; Lan T; Xie Y; Wu H; Meng C; Sun L; Yin Y; Chen X; Jiao X
BMC Immunol; 2018 Jun; 19(1):19. PubMed ID: 29940854
[TBL] [Abstract][Full Text] [Related]
19. Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells.
Kamath AT; Valenti MP; Rochat AF; Agger EM; Lingnau K; von Gabain A; Andersen P; Lambert PH; Siegrist CA
Eur J Immunol; 2008 May; 38(5):1247-56. PubMed ID: 18412160
[TBL] [Abstract][Full Text] [Related]
20. Structure-based vaccines provide protection in a mouse model of ehrlichiosis.
Thomas S; Thirumalapura NR; Crocquet-Valdes PA; Luxon BA; Walker DH
PLoS One; 2011; 6(11):e27981. PubMed ID: 22114733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
